The Open Conference Proceedings Journal


    (Biological Sciences, Chemical Sciences, Physical Sciences, Medicine, Engineering & Technology)



    (Discontinued)

    ISSN: 2210-2892 ― Volume 10, 2020

    Xanthine Oxidase Inhibitory Activity of Tetracera Indica


    The Open Conference Proceedings Journal, 2013, 4: 168

    Fauziah Abdullah, Fadzureena Jamaludin, Nor Hadiani Ismail, Khalid Mohammed Khan, Siti Nur Aisyah Mohd Hashim

    Phytochemistry Programme

    Electronic publication date 1/3/2013
    [DOI: 10.2174/2210289201304010168]




    Abstract:

    Xanthine oxidase (XO) is a key enzyme that catalyzes the last step in the conversion of purines to uric acid, and plays a vital role in producing hyperuricemia and gout. Allopurinol, the medication prescribed for gout prevention, is a xanthine oxidase inhibitor. However, due to unwanted side effects of allopurinol, new alternatives with fewer side effects are desired. In folk remedies, leaves of Tetracera Indica Merr. (Dilleniaceae) are effectively used in the treatment of diabetes and antiinflammatory related diseases. Some studies have proven scientific evidence for the traditional use of leaves of T. indica in the management of diabetes in Malaysia. However, there is no scientific claim about its efficacy in the treatment of antiinflammatory related diseases. Based on literature, Tetracera spesies are widely used for the treatment of anti-inflammatory related diseases. Therefore, the aim of this study is to investigate potential anti-inflammatory activity of T. indica via xanthine oxidase inhibitory assay. Our preliminary screening study revealed that the methanolic extract of the stem of T. indica showed xanthine oxidase inhibitory activity in a concentration-dependent manner. The dried stem of T. indica was extracted with methanol (MeOH), the MeOH solution was evaporated under pressure to give a MeOH extract (73.6g; IC50 42.02 μg/ml). The MeOH extract was suspended in water (H2O) and partitioned successively with hexane, (dichloromethane) DCM, and (ethyl acetate) EA to yield hexane (1.89 g; IC50 > 100 μg/ml), DCM (2.78 g; IC50 > 100 μg/ml), EA (3.80 g; IC50 21.14 μg/ml) and aqueous (59.17 g; IC50 35.36 μg/ml) fractions, respectively. EA fraction was selected to be further study due to its potential to inhibit xanthine oxidase enzyme with IC50 value of 21.14 μg/ml which in lower than IC50 value of MeOH extract, 42.02 μg/ml. Further separation and purification of EA fraction led to the isolation of two known compounds. Those compounds were identified by analysis of their spectroscopic data and comparisons with literature data to be betulinic acid and 5,7-dihydroxyl-8- methoxyflavone.


    Download PDF


    Browse Contents



    Webmaster Contact: info@benthamopen.net
    Copyright © 2024 Bentham Open